{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T14:05:08Z","timestamp":1777817108451,"version":"3.51.4"},"reference-count":51,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Neuropsychopharmacology"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.euroneuro.2009.07.005","type":"journal-article","created":{"date-parts":[[2009,8,5]],"date-time":"2009-08-05T09:30:17Z","timestamp":1249464617000},"page":"861-867","source":"Crossref","is-referenced-by-count":30,"title":["Effects of quetiapine on phencyclidine-induced cognitive deficits in mice: A possible role of \u03b11-adrenoceptors"],"prefix":"10.1016","volume":"19","author":[{"given":"Yuko","family":"Tanibuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Kohno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuto","family":"Takatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Iyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.euroneuro.2009.07.005_bib1","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1038\/sj.npp.1300989","article-title":"Disruption of prepulse inhibition after stimulation of central but not peripheral \u03b11-adrenergic receptors","volume":"31","author":"Alsene","year":"2006","journal-title":"Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s00213-003-1724-3","article-title":"Adrenergic targets for the treatment of cognitive deficits in schizophrenia","volume":"174","author":"Arnsten","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib3","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0006-3223(98)00296-0","article-title":"\u03b11-noradrenergic receptor stimulation impairs prefrontal cortical cognitive function","volume":"45","author":"Arnsten","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib4","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF02246096","article-title":"Antagonism of phencyclidine-induced deficits in prepulse inhibition by the putative atypical antipsychotic olanzapine","volume":"122","author":"Bakshi","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib5","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S0022-3565(24)37049-1","article-title":"Phencyclidine-induced deficits in prepulse inhibition of startle are blocked by prazosin, an \u03b11-noradrenergic antagonist","volume":"283","author":"Bakshi","year":"1997","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0306-4522(98)00752-0","article-title":"\u03b11-adrenergic receptors mediate sensorimotor gating deficits produced by intracerebral dizocilpine administration in rats","volume":"92","author":"Bakshi","year":"1999","journal-title":"Neuroscience"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib7","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0022-3565(25)23831-9","article-title":"Clozapine antagonizes phencyclidine-induced deficits in sensorimotor gating of the startle response","volume":"271","author":"Bakshi","year":"1994","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl.","key":"10.1016\/j.euroneuro.2009.07.005_bib9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1192\/S0007125000296852","article-title":"Do central antiadrenergic actions contribute to the atypical properties of clozapine?","volume":"17","author":"Baldessarini","year":"1992","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib10","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/S0006-3223(99)00138-9","article-title":"A role for norepinephrine in stress-induced cognitive deficits: \u03b11-adrenoceptor mediation in the prefrontal cortex","volume":"46","author":"Birnbaum","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib52","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archpsyc.1990.01810140081011","article-title":"Sensorimotor gating and schizophrenia. Human and animal model studies","volume":"47","author":"Braff","year":"1990","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.euroneuro.2004.10.002","article-title":"Antipsychotics lack \u03b11A\/B adrenoceptor subtype selectivity in the rat","volume":"15","author":"Cahir","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib12","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0028-3908(98)00051-3","article-title":"Disruption in prepulse inhibition after \u03b11-adrenoceptor stimulation in rats","volume":"37","author":"Carasso","year":"1998","journal-title":"Neuropharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib13","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.neulet.2006.03.025","article-title":"Expression of the \u03b11-adrenergic receptor in schizophrenia","volume":"401","author":"Clark","year":"2006","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib14","doi-asserted-by":"crossref","first-page":"2571","DOI":"10.1016\/0024-3205(86)90111-6","article-title":"In vivo potencies of antipsychotic drugs in blocking \u03b11 noradrenergic and dopamine D2 receptors: implications for drug mechanisms of action","volume":"39","author":"Cohen","year":"1986","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib15","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s00213-003-1709-2","article-title":"The NMDA receptor glycine modulatory site: a therapeutic target for improving cognition and reducing negative symptoms in schizophrenia","volume":"174","author":"Coyle","year":"2004","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1001\/archpsyc.1992.01820070032005","article-title":"Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects","volume":"49","author":"Farde","year":"1992","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib17","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJMra035458","article-title":"Schizophrenia","volume":"349","author":"Freedman","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib18","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.biopsych.2004.06.023","article-title":"Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria","volume":"56","author":"Green","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/0014-2999(93)90351-H","article-title":"Prazosin modulates the firing pattern of dopamine neurons in rat ventral tegmental area","volume":"233","author":"Grenhoff","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nrd2806","article-title":"The \u2018atypicality\u2019 of antipsychotics: a concept re-examined and re-defined","volume":"8","author":"Gr\u00fcnder","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib21","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.euroneuro.2007.11.005","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the antipsychotic drug perospirone: role of serotonin 5-HT1A receptors","volume":"18","author":"Hagiwara","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib22","doi-asserted-by":"crossref","first-page":"147","DOI":"10.2174\/1568015043357011","article-title":"Glutamate hypothesis of schizophrenia and approach for possible therapeutic drugs","volume":"4","author":"Hashimoto","year":"2004","journal-title":"Curr. Med. Chem. - CNS Agents"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib23","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol","volume":"519","author":"Hashimoto","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib24","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2174\/1573400054065569","article-title":"Dysfunction of glia-neuron communication in pathophysiology of schizophrenia","volume":"1","author":"Hashimoto","year":"2005","journal-title":"Curr. Psychiatry Rev."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib25","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejphar.2006.09.055","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of tropisetron: role of \u03b17 nicotinic receptors","volume":"553","author":"Hashimoto","year":"2006","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib26","first-page":"514","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of fluvoxamine: role of sigma-1 receptors","volume":"32","author":"Hashimoto","year":"2007","journal-title":"Neuro-psychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib27","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.euroneuro.2007.07.009","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of glycine transporter-1 inhibitor NFPS and D-serine","volume":"18","author":"Hashimoto","year":"2008","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib28","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.biopsych.2007.04.034","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of the novel selective \u03b17 nicotinic receptor agonist SSR180711","volume":"63","author":"Hashimoto","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib29","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bbr.2005.11.014","article-title":"The effects of chronic administration of quetiapine on the phencyclidine-induced reference memory impairment and decrease of Bcl-XL\/Bax ratio in the posterior cingulate cortex in rats","volume":"168","author":"He","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib30","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1176\/ajp.148.10.1301","article-title":"Recent advances in the phencyclidine model of schizophrenia","volume":"148","author":"Javitt","year":"1991","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib31","first-page":"201","article-title":"The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia","volume":"20","author":"Jentsch","year":"1999","journal-title":"Neuro-psychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib32","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1001\/archpsyc.57.6.553","article-title":"A positron emission tomography study of quetiapine in schizophrenia: a preliminary finding of an antipsychotic effect with only transiently high dopamine D2 receptor occupancy","volume":"57","author":"Kapur","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib53","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.2165\/00003495-200767070-00008","article-title":"Quetiapine: a review of its use in the treatment of bipolar depression","volume":"67","author":"Keating","year":"2007","journal-title":"Drugs"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib33","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1007\/s007020070005","article-title":"Subchronic treatment with prazosin improves passive avoidance learning in aged mice: possible relationships to \u03b11-receptor up-regulation","volume":"107","author":"Knauber","year":"2000","journal-title":"J. Neural. Transm."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib34","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0924-977X(00)00100-0","article-title":"Decreased exploratory activity and impaired passive avoidance behaviour in mice deficient for the \u03b11B-adrenoceptor","volume":"10","author":"Knauber","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib35","doi-asserted-by":"crossref","first-page":"125","DOI":"10.3109\/hrp.7.3.125","article-title":"NMDA agonists and antagonists as probes of glutamatergic dysfunction and pharmacotherapies in neuropsychiatric disorders","volume":"7","author":"Krystal","year":"1999","journal-title":"Harv. Rev. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib36","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/0006-8993(88)90390-3","article-title":"Selective inhibition of mesolimbic dopamine release following chronic administration of clozapine: involvement of \u03b11-noradrenergic receptors demonstrated by in vivo voltammetry","volume":"460","author":"Lane","year":"1988","journal-title":"Brain Res."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib54","series-title":"Serotonin in Antipsychotic Treatment \u2013 Mechanisms and Clinical Practice","first-page":"51","article-title":"Serotonin receptor subtypes: possible roles and implications in antipsychotic drug action","author":"Leysen","year":"1996"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib37","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/S0006-3223(99)00139-0","article-title":"Local infusion of an \u03b11-adrenergic agonist into the prefrontal cortex impairs spatial working memory performance in monkeys","volume":"46","author":"Mao","year":"1999","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib38","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0924-977X(00)00077-8","article-title":"Effects of atypical antipsychotic drugs on dopamine output in the shell and core of the nucleus accumbens: role of 5-HT2A and \u03b11-adrenocepror antagonism","volume":"10","author":"Marcus","year":"2000","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0014-2999(96)00315-9","article-title":"Prazosin inhibits MK-801-induced hyperlocomotion and dopamine release in the nucleus accumbens","volume":"309","author":"Math\u00e9","year":"1996","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib40","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/sj.mp.4002066","article-title":"Atypical antipsychotic-induced metabolic side effects: insights from receptor-binding profiles","volume":"13","author":"Nasrallah","year":"2008","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib43","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1176\/ajp.137.12.1518","article-title":"Relationship of neuroleptic drug effects at brain dopamine, serotonin, \u03b1-adrenergic, and histamine receptors to clinical potency","volume":"137","author":"Peroutka","year":"1980","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib44","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pharmthera.2006.11.006","article-title":"Adrenergic pharmacology and cognition: focus on the prefrontal cortex","volume":"113","author":"Ramos","year":"2007","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib45","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0024-3205(00)00911-5","article-title":"Binding of antipsychotic drugs to human brain receptors. Focus on newer generation compounds","volume":"68","author":"Richelson","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/sj.bjp.0704451","article-title":"Effects of phencyclidine (PCP) and MK-801 on the EEGq in the prefrontal cortex of conscious rats; antagonism by clozapine, and antagonists of AMPA-, \u03b11- and 5-HT2A-receptors","volume":"135","author":"Sebban","year":"2002","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib47","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1006\/nlme.2000.3965","article-title":"A behavioral study of alpha-1b adrenergic receptor knockout mice: increased reaction to novelty and selectively reduced learning capacities","volume":"75","author":"Spreng","year":"2001","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib48","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/j.pnpbp.2003.09.009","article-title":"\u03b1-adrenoceptor modulation hypothesis of antipsychotic atypicality","volume":"27","author":"Svensson","year":"2003","journal-title":"Prog. Neuro-psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.euroneuro.2009.07.005_bib49","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0031-9384(02)00936-8","article-title":"Impaired prefrontal inhibition in schizophrenia: relevance for cognitive dysfunction","volume":"77","author":"Volk","year":"2002","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib50","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1007\/s007020070036","article-title":"Enhancement of antipsychotic-like effects by combined treatment with the \u03b11-adrenoceptor antagonist prazosin and the dopamine D2 receptor antagonist raclopride in rats","volume":"107","author":"Wadenberg","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.euroneuro.2009.07.005_bib51","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0304-3940(02)00034-4","article-title":"Quetiapine attenuates the immobilization stress-induced decrease of brain-derived neurotrophic factor expression in rat hippocampus","volume":"321","author":"Xu","year":"2002","journal-title":"Neurosci. Lett."}],"container-title":["European Neuropsychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09001710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0924977X09001710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:48:40Z","timestamp":1739292520000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0924977X09001710"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":51,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0924977X09001710"],"URL":"https:\/\/doi.org\/10.1016\/j.euroneuro.2009.07.005","relation":{},"ISSN":["0924-977X"],"issn-type":[{"value":"0924-977X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,12]]}}}